← Back to Search

Quidel quickvue antigen test for COVID-19 for Coronavirus

N/A
Waitlist Available
Led By Aksay Sood, MD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test if point-of-care molecular testing can be used to effectively monitor and prevent the spread of SARS-CoV-2 infection in a population of high-risk, rural essential workers.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Screened (Molecular)
Secondary outcome measures
Diagnostic test (RT-PCR)
Serologic antibody test

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention SiteExperimental Treatment1 Intervention
All miners in the New Mexico intervention mine site who will be administered nasal swabs for antigen testing every other work shift, and serological testing 3 months.
Group II: Controled siteActive Control1 Intervention
All miners in the Wyoming Control mine site who will be administered serological testing 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Quidel quickvue antigen test for COVID-19
2021
N/A
~230

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,559 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,690 Previous Clinical Trials
6,950,778 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
268 Previous Clinical Trials
248,588 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
The Journal of Rural HealthJournal
Caring for Miners During the Coronavirus Disease‐2019 (COVID‐19) Pandemic
Sood, Akshay, Charles Pollard, Kyla Le Suer, Kevin Vlahovich, and Jolene Walker. 2020. “Caring for Miners During the Coronavirus Disease‐2019 (COVID‐19) Pandemic”. The Journal of Rural Health. Wiley. doi:10.1111/jrh.12444.
clinicaltrials.govStudy
The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners
2021. "The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04977050.
~56 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top